Research paperAssessment of distance from skin surface to muscle for evaluation of the risk of inadvertent intramuscular insulin injection at potential injection sites among patients attending a tertiary care children's hospital in Sri Lanka–an observational study
Introduction
Diabetes mellitus is classified into two subtypes: type 1 and type 2. Since insulin production is typically absent in type 1 diabetes (DM), subcutaneous insulin therapy is mandatory to achieve optimal glycemic control [1]. The optimum management of DM is a complex process that warrants both pharmacological and non-pharmacological approaches, such as subcutaneous insulin administration, diet and lifestyle modification, as well as behavioral and psychological counseling [2], [3]. Satisfactory glycemic control is key to preventing short- and long-term complications of diabetes, which is an unrealistic goal if the compliance to insulin therapy is poor [3].
The reasons for poor compliance with diabetes treatment are multifactorial, among which, the development of needle phobia due to pain and bleeding during insulin injections is eminent. Symptoms of hypoglycemia, a well-known side effect of insulin treatment, is another factor directly related to poor compliance and needle phobia [2], [4], [5], [6]. Intramuscular insulin injections (IM) or an accidental injection into a muscle is associated with symptomatic hypoglycemia and a variable degree of pain at the injection site. It is known that the incidence of IM injections is related to the skin thickness, the length of the insulin needle, and the insulin administration technique [4], [5], [7]. Although the suitable length of insulin needles is a widely discussed topic, only a few studies focused on the desired needle length for pediatric populations [5], [6], [8], [9], [10].
The ideal subcutaneous injection needle should have a high probability to enter and remain within the subcutaneous tissue. Therefore, it should be long enough to penetrate the dermal layer (low risk of intradermal injections) while being shorter than the skin-to-muscle distance (low risk of IM injections) [4]. In 90-degree injection technique, the needle is placed perpendicular to the skin surface. Hence, the dermal thickness and skin-to-muscle distance (skin thickness) measurements are crucial for determining the intradermal and intramuscular injection risks, respectively. Therefore, dermal thickness and skin thickness measurements determine the correct needle length for a particular patient. Ultrasonography is a reliable noninvasive technique to measure dermal and subcutaneous thicknesses, hence to assess the risk of intradermal and intramuscular injections [11].
Skin thickness in a child is affected by age, pubertal status, gender, body mass index (BMI), and the anatomical site. The racial variation described for skin thickness is probably related to the genetic influence on body composition [8], [12]. Due to the scarcity of data, the needle lengths prescribed for Sri Lankan children are based on Western reference values [13]. However, owing to racial variations, currently used needles may or may not be suitable for many children. This study aimed to evaluate the dermal and subcutaneous thicknesses of potential insulin injection sites of a selected pediatric population so as to determine the IM injection risk for different needle lengths, and thereby determine the suitable needle length.
Section snippets
Study population
The current study examined both diabetic (DM; n = 44) and non-diabetic children (n = 81) aged 2–14 years. Children with type 1 diabetes mellitus were recruited from the diabetic clinic at Lady Ridgeway Hospital for Children. Since the number of DM children attending the healthcare institution was inadequate, age- and sex-matched, non-diabetic children who presented for ultrasound scans at the same institution were recruited to strengthen the sample. All DM children were on subcutaneously
Results
The study examined children with type 1 DM (n = 44) and children without DM (n = 81) in two age groups: 2–6 years (n = 45) and 7–14 years (n = 80); the mean age was 8 ± 4 years. Of the children, 57% were boys, with no statistically significant age difference (P = 0.085) between girls and boys (Table 1, Table 2). A significant age difference was observed between the DM and non-DM groups (P < 0.05). As expected, a growth-related change in the study parameters was evident in all groups: weight, height, BMI,
Discussion
IM insulin injections can lead to fluctuations in blood glucose levels, needle phobia, and poor compliance to insulin treatment. The injection-related pain, which contributes to needle phobia, occurs when the highly innervated muscle is accidentally pricked. IM risk is known to be associated with the needle length [4], [5]. Therefore, selecting a needle with appropriate length (for subcutaneous insulin administration) is fundamental to achieve an optimal glycemic control [4], [7]. As a pioneer
Conclusion
An individualized approach in prescribing needles and injection sites, considering the age and gender of the child, would reduce the incidence of IM injections. Short insulin needles (5 mm or shorter) are suitable for children with type 1 DM, particularly for the 2–6-year age group, and for boys of any age. The anterior abdominal wall can be recommended as the preferable injection site, particularly for boys; for limb injections, use of a correct injection technique is mandatory. However,
Disclosure of interest
The authors declare that they have no competing interest.
Financial support
This research was not funded by any financial agent/group.
Ethical approval
Ethical approval was granted by the Ethics Review Committee, Faculty of Medicine University of Colombo, on 29.10.2015. Reference number EC-14-149.
References (17)
- et al.
Epidemiology of type 1 diabetes
Endocrinol Metab Clin North Am
(2010) - et al.
Challenges in Type 1 diabetes management in South East Asia: descriptive situational assessment
Indian J Endocrinol Metab
(2014) - et al.
Factors associated with non-adherence to insulin in patients with Type-1 diabetes
Pak J Med Sci
(2014) The role of comfort and discomfort in insulin therapy
Diabetes Technol Ther
(2012)- et al.
Skinny-skin thickness and needles in the young
S Afr J Child Health
(2014) - et al.
Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults
Diabetes Care
(1997) - et al.
Effects of accidental intramuscular injection on insulin absorption in IDDM
Diabetes Care
(1988) - et al.
Effects of age, gender, BMI and anatomical site on skin thickness in children and adults with diabetes
PLoS ONE
(2014)
Cited by (1)
Inadvertent intramuscular injection risk with subcutaneous insulin injections and risk predictors in adults: a cross-sectional sonographic study
2023, International Journal of Diabetes in Developing Countries